A prospective comparative interventional study of diclofenac gel plus ormeloxifene versus diclofenac gel plus evening primrose oil in the treatment of mastalgia in benign breast diseases.

Authors

  • Upendra yadav Resident, Department of General Surgery, BRD Medical College, Gorakhpur, Uttar Pradesh, India
  • Deepak Singh Assistant Professor, Department of General surgery, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India.
  • Aquil Ahmad Assistant Professor, Department of General surgery, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India.
  • Ujjwal Awasthi Junior Resident, Department of General surgery, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India.
  • Prof Ashok Kumar Professor Department of General surgery, BRD Medical College, Gorakhpur, Uttar Pradesh, India.

DOI:

https://doi.org/10.51168/sjhrafrica.v6i6.1885

Keywords:

Mastalgia, Benign Breast Disease, Diclofenac Gel, Ormeloxifene, Evening Primrose Oil

Abstract

Background

Mastalgia, a common symptom of benign breast diseases, affects women's quality of life. This study aimed to compare the efficacy of diclofenac gel plus ormeloxifene versus diclofenac gel plus evening primrose oil in the treatment of mastalgia in benign breast diseases.

Methods

The study analyzed 100 female patients aged 18-45 with mastalgia in the Department of General Surgery at BRD Medical College, Gorakhpur, between 2023 and 2024. The patients were divided into two groups: Group A (diclofenac gel + ormeloxifene 30 mg twice weekly for 3 months) and Group B (diclofenac gel + evening primrose oil 1000 mg twice daily for 3 months).

Results

At baseline, both groups had comparable VAS scores (6.76 ± 1.45 in Group A vs. 6.40 ± 1.64 in Group B, p = 0.248). At 1 month, VAS scores decreased in both groups (4.30 ± 1.47 in Group A vs. 4.70 ± 1.66 in Group B, p = 0.205), with no significant difference. However, at 3 months, the VAS score reduction was significantly greater in Group A (1.36 ± 1.74) compared to Group B (2.84 ± 2.05) (p < 0.001), indicating superior pain relief with ormeloxifene. Intra-group analysis showed a significant reduction in pain over time in both groups (p < 0.001). A higher proportion of participants in Group A (76.00%) showed significant improvement compared to 40.00% in Group B (p = 0.001).

Conclusion

Ormeloxifene, when combined with diclofenac gel, demonstrated superior efficacy in reducing mastalgia symptoms compared to evening primrose oil, indicating its superior treatment option for benign breast diseases.

Recommendation

It recommends individualized treatment based on symptom severity, patient preference, and tolerance. Regular follow-up is recommended for pain relief, adherence, and side effects. Further large-scale studies are needed for validation and standardized treatment protocols.

References

Millet A.V., Dirbas F.M. Clinical management of breast pain: A review. Obstet. Gynecol. Surv. 2002;57:451-461. https://doi.org/10.1097/00006254-200207000-00022

Mansel R.E., Goyal A., Preece P., Leinster S., Maddox P.R., Gateley C., Kubista E., von Fournier D. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. Am. J. Obstet. Gynecol. 2004;191:1942-1949. https://doi.org/10.1016/j.ajog.2004.06.100

Santen R.J., Mansel R. Benign breast disorders. N. Engl. J. Med. 2005;353:275-285. doi: 10.1056/NEJMra035692. https://doi.org/10.1056/NEJMra035692

Pruthi S., Wahner-Roedler D.L., Torkelson C.J., Cha S.S., Thicke L.S., Hazelton J.H., Bauer B.A. Vitamin E and Evening Primrose Oil for management of cyclical mastalgia: A randomized Pilot Study. Altern. Med. Rev. 2010;15:59-67.

Gautam S., Srivastava A., Kataria K., Dhar A., Ranjan P., Kumar J. New Breast Pain Chart for Objective Record of Mastalgia. Indian J. Surg. 2016;78:245-248. https://doi.org/10.1007/s12262-016-1492-z

Eren T., Aslan A., Ozemir I.A., Baysal H., Sagiroglu J., Ekinci O., Alimoglu O. Factors Effecting Mastalgia. Breast Care (Basel) 2016;11:188-193. https://doi.org/10.1159/000444359

Mansel R.E., Webster D.J.T., Sweetland H.M. Breast Pain and Nodularity. Elsevier; Amsterdam, The Netherlands: 2009. p. 365. https://doi.org/10.1016/B978-0-7020-2774-1.00012-8

Gregory P.L., Biswas A.C., Batt M.E. Musculoskeletal problems of the chest wall in athletes. Sports Med. 2002;32:235-250. https://doi.org/10.2165/00007256-200232040-00003

Kumar S., Mansel R.E., Scanlon M.F., Hughes L.E., Edwards C.A., Woodhead J.S., Newcombe R.G. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br. J. Surg. 1984;71:870-873. https://doi.org/10.1002/bjs.1800711123.

Fan Y.Y., Chapkin R.S. Importance of dietary gamma-linolenic acid in human health and nutrition. J. Nutr. 1998;128:1411-1414. https://doi.org/10.1093/jn/128.9.1411

Holland PA, Gateley CA. Drug therapy of mastalgia. What are the options? Drugs. 1994 Nov;48(5):709-16.

https://doi.org/10.2165/00003495-199448050-00005

Horrobin D.F., Manku M.S. Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): Disorders of essential fatty acid (EFA) metabolism. Prostaglandins Leukot. Essent. Fat. Acids. 1989;37:255-261. https://doi.org/10.1016/0952-3278(89)90036-7

Brahmachari S, Bhagat V, Patil P, Vasuniya V. Evaluating the Effect of Ormeloxifene on Multiple Fibroadenomas and Mastalgia. J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1386-S1389. https://doi.org/10.4103/jpbs.jpbs_222_21

Chen ZR, Chen BK, Li P, Feng K. Efficacy and safety of different topical diclofenac formulations for the treatment of knee osteoarthritis: a meta-analysis of short-term and long-term treatment comparisons. BMC Musculoskelet Disord. 2025 Mar 10;26(1):230. https://doi.org/10.1186/s12891-025-08465-7

Cornell LF, Sandhu NP, Pruthi S, Mussallem DM. Current Management and Treatment Options for Breast Pain. Mayo Clin Proc. 2020 Mar;95(3):574-580. https://doi.org/10.1016/j.mayocp.2019.12.014

Olawaiye A, Withiam-Leitch M, Danakas G, Kahn K. Mastalgia: a review of management. J Reprod Med. 2005 Dec;50(12):933-9.

Kumar S, Rai R, Agarwal GG, Dwivedi V, Kumar S, Das V. A randomized, double- blind, placebocontrolled trial of ormeloxofene in breast pain and nodularity. The National Medical Journal of India. 2013;26(2):69-74.

NoopurMishra, Singh P. Comparative Study Of The Efficacy of Ormeloxifene, Danazoland Evening Primrose Oil On Treatment Of Breast Nodularity. Indian Journal of Applied Research. 2020;10:45-47.

Nigam, A., Goenka, A. & Shrivastava, N. A Comparative Study of Effect of Ormeloxifene and Evening Primrose Oil in Treatment of Mastalgia. Indian J Surg 81, 259-264 (2019). https://doi.org/10.1007/s12262-018-1793-5

AhluwaliaAS,BhatiaP,ChhabraAS. A comparative study of centchroman versus evening primrose oil in treatment of mastalgia. Int Surg J2021;8:331-8. https://doi.org/10.18203/2349-2902.isj20205900

Ahmad Adni LL, Norhayati MN, Mohd Rosli RR, Muhammad J. A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment. Int J Environ Res Public Health. 2021 Jun 10;18(12):6295. doi: 10.3390/ijerph18126295. PMID: 34200727; PMCID: PMC8296106. https://doi.org/10.3390/ijerph18126295

Brahmachari S, Bhagat V, Patil P, Vasuniya V. Evaluating the Effect of Ormeloxifene on Multiple Fibroadenomas and Mastalgia. J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1386-S1389. https://doi.org/10.4103/jpbs.jpbs_222_21

Anupam Banerjee, Dipan Mukhopadhyay, Tapati Mondal, Swarup Chakraborty. An observational study comparing ormeloxifene with evening primrose oil for benign breast diseases. Asian Journal of Medical Sciences 2023; 14 (7):117-122. https://doi.org/10.3126/ajms.v14i7.51995 https://doi.org/10.71152/ajms.v14i7.3705

Ashish Trehan Dr. Ashish Moudgil Dr. Ravi Kale. Comparing The Clinical Response Of Ormeloxifene, Evening Primrose Oil And Topical Diclofenac For Treatment Of Mastalgia In Benign Breast Disorders. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2024;23:05-07. https://doi.org/10.9790/0853-2312040507

Sinha N, Tajdar Y, Pankaj D, Kumar N, Muni S, Bhushan V. A Study Comparing Centchroman and Evening Primrose Oil in the Treatment of Benign Breast Disease. J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1544-S1548. https://doi.org/10.4103/jpbs.jpbs_399_23

Downloads

Published

2025-06-30

How to Cite

yadav, U., Singh, D. ., Ahmad, D. A., Awasthi, U., & Kumar, P. A. (2025). A prospective comparative interventional study of diclofenac gel plus ormeloxifene versus diclofenac gel plus evening primrose oil in the treatment of mastalgia in benign breast diseases. Student’s Journal of Health Research Africa, 6(6), 12. https://doi.org/10.51168/sjhrafrica.v6i6.1885

Issue

Section

Other Original Articles